Css LLC Amicus Therapeutics, Inc. Put Options Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $226,746 - $381,672	-34,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $110,676 - $182,850	13,800 Added 67.65%	34,200 $274,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $220,296 - $289,440	-20,100 Reduced 49.63%	20,400 $255,000
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $406,619 - $563,760	40,500 New	40,500 $550,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $280,982 - $365,726	-21,400 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $27,520 - $34,240	-2,000 Reduced 8.55%	21,400 $322,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $267,714 - $347,535	21,400 Added 1070.0%	23,400 $337,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $23,480 - $31,560	2,000	2,000 $30,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.